-
Migraine and Subclinical Brain Lesions; Memantine Treatment in Alzheimer Disease; PPG in Type 2 DM
-
Sulfonamide Antibiotics and Sulfonamide Nonantibiotics; Autoantibodies
Before Onset of SLE; Prevention of VTE with Ximelagatran; Combined
Levothyroxine Plus Liothyronine Compared to Levothyroxine Alone in
Primary Hypothyroidism; Specific Site Involvement in Fixed Drug
Eruption; Anticoagulation Therapy for Stroke Prevention in Patients
with Atrial Fibrillation
-
These data provide further support that inflammation in general and periodontal disease more specifically are stroke risk factors.
-
The first of a class of calcimimetics has been approved by the FDA for the treatment of hyperparathyroidism associated with renal failure and in patients with parathyroid cancer.
-
High-dose atorvastatin protects patients with acute coronary syndrome from death and major cardiovascular events better than usual dose pravastatin.
-
Increased iron stores (eg, ferritin levels) are associated with an increased risk of type 2 diabetes in women.
-
Shared pathophysiologic mechanisms for migraine, neuropathic pain, and epilepsy underscore the notion that antiepileptic drugs (AED) should be standard treatment for the former. Five new AEDs and their use in these nonepileptic painful disorders are summarized.
-
-
Use of B-Type Natriuretic Peptide in the Evaluation and Management of
Acute Dyspnea; Association Between C-Reactive Protein and Age-Related Macular Degeneration; VZV Reactivation in Astronauts
-